Octaplas (human plasma proteins) NDC 68982-952

Product information

Brand name (proprietary)

Octaplas

Generic name (nonproprietary)

human plasma proteins

Active ingredients

Plasma protein fraction (Human) — 11.5 g/200mL

Dosage form

Solution

Route

Intravenous

Labeler

Octapharma USA Inc

Product type

Plasma derivative

Marketing category

BLA — Biologics License ApplicationApplication BLA 125416

Marketing start

Jul 18, 2013

Listing expires

Dec 31, 2026

Identifiers

Product ID 68982-952_c1131de7-0267-f984-d076-09a20b210f6eSPL ID c1131de7-0267-f984-d076-09a20b210f6e

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468982095201 followed by a unit qualifier and the quantity Copy

Package 68982-0952-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125416

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.